Novavax Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (48)

Latest Posts

About This Stock More About This Stock
3 Biotech Stocks Poised For Massive Future Growth
Article By: ValueWalk
Wednesday, September 16, 2020 10:49 AM EDT
The biotech sector has received a lot of attention and hype lately because of the COVID-19 pandemic.
In this article: MRNA, NVAX, BNTX Also: GILD, SRNE, AZN, PFE
Read
E Market Briefing For Wednesday, September 9
Article By: Gene Inger
Wednesday, September 9, 2020 3:58 AM EDT
S&P and big-cap-led Nasdaq continue cratering, not helped by the Apple hit, but particularly NDX, as the oft-warned about situation with Tesla unwinds.
In this article: AZN, GSK, JNJ, MRK, PFE, SNYNF, SRNE, NVAX, AAPL, SPY, MRNA, HTBX Also: QQQ, SPX, NYA, NDX
Read
Novavax Buy Target: Chart Analysis
Article By: Gareth Soloway
Monday, August 24, 2020 4:10 PM EDT
Shares of Novavax Inc are falling sharply today, unwinding a major overbought condition.
In this article: NVAX
Read
E Market Briefing For Monday, Aug. 24
Article By: Gene Inger
Sunday, August 23, 2020 9:04 PM EDT
In 2020 the driving determining force in this market has been twofold: the power of concentration in a few incredible 'super-caps', and of course Covid-19; including avoidance of so many sectors both on the way down and back up.
In this article: NVAX, AAPL, SPX Also: HTBX, PFE, SRNE, QQQ, AMZN, GILD, TSLA, MRNA, GOOGL
Read
NVAX Stock Price: Novavax, Inc. Keeps The $143.00 Mark So Far
Article By: FXStreet
Friday, August 21, 2020 12:25 PM EDT
Novavax, Inc. trades around Thursday’s close near $143.00.
In this article: NVAX
Read

PARTNER HEADLINES

Latest Tweets for $NVAX

No tweets yet!

$NVAX

Novavax Analyst Says COVID-19 Vaccine Could Net $400M In Yearly Sales
Barry Hochhauser 7/1/2020 11:58:02 PM

Analyst can actually think a #Covid19 vaccine will only cost $.40 each since $NVAX has stated that they expect to produce 1 billlion doses in 2021, does he?

1 to 1 of 1 comments